Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

212
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
212
Dementia01:30

Dementia

139
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
139
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

517
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
517
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

165
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
165
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

12
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
12
Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

155
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
155

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluating Differentially Private Synthetic Data for Multi-Site Clinical Research: A Case Study from 5 Swiss University Hospitals.

Studies in health technology and informatics·2026
Same author

[Carotid artery stenosis : from diagnosis to treatment].

Revue medicale suisse·2026
Same author

Revue medicale suisse·2026
Same author

[A perspective on the year 2025 by hospital internists].

Revue medicale suisse·2026
Same author

Contribution of quantitative I-123-ioflupane SPECT/CT to the differential diagnosis of dementia with lewy bodies.

European journal of nuclear medicine and molecular imaging·2025
Same author

Revue medicale suisse·2025

Related Experiment Video

Updated: Jul 17, 2025

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
12:28

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Published on: June 3, 2020

17.4K

[Rapidly progressive dementia: management by the internist].

Thibaut Jossein1, David Ruchat1, Jean Regina1

  • 1Service de médecine interne et de soins intensifs, Hôpital de Nyon, 1260 Nyon.

Revue Medicale Suisse
|September 6, 2023
PubMed
Summary

Rapidly progressive dementia has a swift onset, differing from other neurocognitive disorders. Prompt diagnosis and management are crucial for conditions like Creutzfeldt-Jakob disease.

More Related Videos

Assessment of Dependence in Activities of Daily Living Among Older Patients in an Acute Care Unit
06:52

Assessment of Dependence in Activities of Daily Living Among Older Patients in an Acute Care Unit

Published on: September 30, 2020

9.8K
The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
06:23

The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease

Published on: October 13, 2016

32.4K

Related Experiment Videos

Last Updated: Jul 17, 2025

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
12:28

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Published on: June 3, 2020

17.4K
Assessment of Dependence in Activities of Daily Living Among Older Patients in an Acute Care Unit
06:52

Assessment of Dependence in Activities of Daily Living Among Older Patients in an Acute Care Unit

Published on: September 30, 2020

9.8K
The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
06:23

The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease

Published on: October 13, 2016

32.4K

Area of Science:

  • Neurology
  • Neuroscience
  • Geriatrics

Context:

  • Rapidly progressive dementia (RPD) presents with cognitive decline over less than two years.
  • RPD encompasses diverse etiologies, including neurodegenerative diseases and infections.
  • Distinguishing RPD from other cognitive impairments is critical for timely intervention.

Purpose:

  • To define the diagnostic criteria for rapidly progressive dementia.
  • To outline the essential work-up for patients presenting with rapid cognitive decline.
  • To emphasize the importance of early specialist referral in managing RPD.

Summary:

  • RPD is characterized by rapid cognitive deterioration, necessitating differentiation from delirium and other acute neurological events.
  • Diagnostic evaluation involves comprehensive history, clinical assessment, and investigations such as MRI, lumbar puncture, and EEG.
  • Prompt neurological consultation is vital for effective management of rapidly progressive dementia.

Impact:

  • Facilitates earlier and more accurate diagnosis of rapidly progressive dementia.
  • Guides clinicians in the systematic evaluation of patients with acute cognitive decline.
  • Improves patient outcomes through timely initiation of appropriate treatment and care pathways.